Search research articles
Contact Us
Filters
Showing results (21-30 of 40) with videos related to
Page
of 4
Sort By:
Cancer Research
|
February 9, 2013
Amplification of FRS2 and activation of FGFR/FRS2 signaling pathway in high-grade liposarcoma
Keqiang Zhang, Kevin Chu, Xiwei Wu, et al.
Cancer Chemotherapy and Pharmacology
|
October 20, 2006
A phase I study of oxaliplatin in combination with gemcitabine: correlation of clinical outcome with gene expression
Stephen Shibata, Warren Chow, Paul Frankel, et al.
Cancer Chemotherapy and Pharmacology
|
January 29, 2010
Plasma and cerebrospinal fluid pharmacokinetics of topotecan in a phase I trial of topotecan, tamoxifen, and carboplatin, in the treatment of recurrent or refractory brain or spinal cord tumors
Robert J Morgan, Timothy Synold, Adam Mamelak, et al.
Cancer Chemotherapy and Pharmacology
|
November 20, 2002
Phase I pharmacodynamic study of time and sequence dependency of hydroxyurea in combination with gemcitabine: a California Cancer Consortium Trial
Yun Yen, Warren Chow, Lucille Leong, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
November 9, 2005
Paclitaxel-based high-dose chemotherapy with autologous stem cell rescue for relapsed germ cell cancer
Kim A Margolin, James H Doroshow, Paul Frankel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 19, 2021
A Randomized Phase II Study of Nivolumab Monotherapy or Nivolumab Combined with Ipilimumab in Patients with Advanced Gastrointestinal Stromal Tumors
Arun S Singh, J Randolph Hecht, Lee Rosen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 17, 2003
Phase I trial of intraperitoneal docetaxel in the treatment of advanced malignancies primarily confined to the peritoneal cavity: dose-limiting toxicity and pharmacokinetics
Robert J Morgan, James H Doroshow, Timothy Synold, et al.
Cancer Chemotherapy and Pharmacology
|
April 16, 2003
Phase I study of cisdiamminedichloroplatinum in combination with azidothymidine in the treatment of patients with advanced malignancies
Robert J Morgan, Edward M Newman, Lawrence Sowers, et al.
Journal of the American College of Surgeons
|
May 1, 2013
Optimizing ACS NSQIP modeling for evaluation of surgical quality and risk: patient risk adjustment, procedure mix adjustment, shrinkage adjustment, and surgical focus
Mark E Cohen, Clifford Y Ko, Karl Y Bilimoria, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 15, 2004
Prognostic indicators and survival in patients with stage IIIB inflammatory breast carcinoma after dose-intense chemotherapy
George Somlo, Paul Frankel, Warren Chow, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 40) with videos related to
Sort By:
Page
of 4
Cancer Research
|
February 9, 2013
Amplification of FRS2 and activation of FGFR/FRS2 signaling pathway in high-grade liposarcoma
Keqiang Zhang, Kevin Chu, Xiwei Wu, et al.
Cancer Chemotherapy and Pharmacology
|
October 20, 2006
A phase I study of oxaliplatin in combination with gemcitabine: correlation of clinical outcome with gene expression
Stephen Shibata, Warren Chow, Paul Frankel, et al.
Cancer Chemotherapy and Pharmacology
|
January 29, 2010
Plasma and cerebrospinal fluid pharmacokinetics of topotecan in a phase I trial of topotecan, tamoxifen, and carboplatin, in the treatment of recurrent or refractory brain or spinal cord tumors
Robert J Morgan, Timothy Synold, Adam Mamelak, et al.
Cancer Chemotherapy and Pharmacology
|
November 20, 2002
Phase I pharmacodynamic study of time and sequence dependency of hydroxyurea in combination with gemcitabine: a California Cancer Consortium Trial
Yun Yen, Warren Chow, Lucille Leong, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
November 9, 2005
Paclitaxel-based high-dose chemotherapy with autologous stem cell rescue for relapsed germ cell cancer
Kim A Margolin, James H Doroshow, Paul Frankel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 19, 2021
A Randomized Phase II Study of Nivolumab Monotherapy or Nivolumab Combined with Ipilimumab in Patients with Advanced Gastrointestinal Stromal Tumors
Arun S Singh, J Randolph Hecht, Lee Rosen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 17, 2003
Phase I trial of intraperitoneal docetaxel in the treatment of advanced malignancies primarily confined to the peritoneal cavity: dose-limiting toxicity and pharmacokinetics
Robert J Morgan, James H Doroshow, Timothy Synold, et al.
Cancer Chemotherapy and Pharmacology
|
April 16, 2003
Phase I study of cisdiamminedichloroplatinum in combination with azidothymidine in the treatment of patients with advanced malignancies
Robert J Morgan, Edward M Newman, Lawrence Sowers, et al.
Journal of the American College of Surgeons
|
May 1, 2013
Optimizing ACS NSQIP modeling for evaluation of surgical quality and risk: patient risk adjustment, procedure mix adjustment, shrinkage adjustment, and surgical focus
Mark E Cohen, Clifford Y Ko, Karl Y Bilimoria, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 15, 2004
Prognostic indicators and survival in patients with stage IIIB inflammatory breast carcinoma after dose-intense chemotherapy
George Somlo, Paul Frankel, Warren Chow, et al.
Page
of 4